ConductScience.org, home

Paper40844293

Adoptive T-cell therapy for virus-associated diseases.

Smith C and 1 other. Clin Microbiol Rev, 2025. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Adoptive T-cell therapy for virus-associated diseases. Papers, record 40844293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40844293

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adoptive T-cell therapy for virus-associated diseases.
PubMed
Journal
Clin Microbiol Rev
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-08-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith CCoreyhttps://orcid.org/0000-0002-7550-9595
2Khanna RRajivhttps://orcid.org/0000-0003-2241-0353

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Virus DiseasesMajor topic
Immunotherapy, AdoptiveMajor topic
T-LymphocytesMajor topic
Adoptive TransferMajor topic
Humans
Hematopoietic Stem Cell Transplantation

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
GNT1132519National Health and Medical Research CouncilPubMed

Source PubMed

Download CSV of grants

References368

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123610374Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.Blood2013https://conductscience.org/library/papers/23610374PubMed
238605438The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation.Transplantation2024https://conductscience.org/library/papers/38605438PubMed
320948438Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma.J Immunother2010https://conductscience.org/library/papers/20948438PubMed
433742086Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma.NPJ Precis Oncol2021https://conductscience.org/library/papers/33742086PubMed
540011760TCR catch bonds nonlinearly control CD8 cooperation to shape T cell specificity.Cell Res2025https://conductscience.org/library/papers/40011760PubMed
638593233Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients.Blood Adv2024https://conductscience.org/library/papers/38593233PubMed
733131188Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study.Am J Transplant2021https://conductscience.org/library/papers/33131188PubMed
822806594Rapid salvage treatment with virus-specific T cells for therapy-resistant disease.Clin Infect Dis2012https://conductscience.org/library/papers/22806594PubMed
914585640Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.Lancet2003https://conductscience.org/library/papers/14585640PubMed
1027793552Herpes simplex virus type 1 (HSV-1) specific T-cell generation from HLA-A1- and HLA-A2-positive donors for adoptive immunotherapy.Cytotherapy2017https://conductscience.org/library/papers/27793552PubMed
1119880495Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.Blood2010https://conductscience.org/library/papers/19880495PubMed
1224493474Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.Mult Scler2014https://conductscience.org/library/papers/24493474PubMed
1317372003T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection.J Immunol2007https://conductscience.org/library/papers/17372003PubMed
1431341086Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/31341086PubMed
1535595631Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipient.J Heart Lung Transplant2022https://conductscience.org/library/papers/35595631PubMed
1624876563Current concepts in the diagnosis and management of cytokine release syndrome.Blood2014https://conductscience.org/library/papers/24876563PubMed
1729296867Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells.Blood Adv2017https://conductscience.org/library/papers/29296867PubMed
1830249388HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.Mol Ther2018https://conductscience.org/library/papers/30249388PubMed
198051277Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients.J Clin Microbiol1994https://conductscience.org/library/papers/8051277PubMed
2020103780Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.Blood2010https://conductscience.org/library/papers/20103780PubMed

See all 368 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42198688Epstein-Barr Virus-Positive Primary CNS Lymphoma in a Patient Receiving Mycophenolate Mofetil: Diagnostic and Therapeutic Considerations.Viruses2026https://conductscience.org/library/papers/42198688PubMed
42148104Adapting CAR-T and CAR-Treg cancer therapies for autoimmunity: innovations and challenges.Front Immunol2026https://conductscience.org/library/papers/42148104PubMed
41594592BK Polyomavirus in Renal Transplantation: Virological Notes for Monitoring and Diagnosis.Biomolecules2025https://conductscience.org/library/papers/41594592PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40844293

GET https://conductscience.org/api/papers/v1/40844293/references?page=2